{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:30:03Z","timestamp":1785727803274,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"GACR","doi-asserted-by":"publisher","award":["17-04047S"],"award-info":[{"award-number":["17-04047S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AZV","award":["15-34524A"],"award-info":[{"award-number":["15-34524A"]}]},{"name":"IPHYS","award":["67985823"],"award-info":[{"award-number":["67985823"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.physbeh.2019.01.013","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T17:50:29Z","timestamp":1551376229000},"page":"241-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder"],"prefix":"10.1016","volume":"204","author":[{"given":"Martina","family":"Janikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Brozka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Radostova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-5347","authenticated-orcid":false,"given":"Jan","family":"Svoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Stuchlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.physbeh.2019.01.013_bb0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00970540","article-title":"Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies","volume":"20","author":"Abarca","year":"1995","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neubiorev.2004.11.006","article-title":"The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers","volume":"29","author":"Chamberlain","year":"2005","journal-title":"Neurosci. Behav. Rev."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0015","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1176\/ajp.2006.163.7.1282","article-title":"Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania","volume":"163","author":"Chamberlain","year":"2006","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.physbeh.2019.01.013_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/ajp.2007.164.2.335","article-title":"Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder","volume":"154","author":"Chamberlain","year":"2007","journal-title":"Am. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.physbeh.2019.01.013_bb0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2005.04.043","article-title":"Riluzole augmentation in treatment-resistant obsessive\u2013compulsive disorder: an open-label trial","volume":"58","author":"Coric","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.physbeh.2019.01.013_bb0030","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1523\/JNEUROSCI.4467-08.2009","article-title":"Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration","volume":"29","author":"Cools","year":"2009","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.physbeh.2019.01.013_bb0035","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/nn1923","article-title":"Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens","volume":"10","author":"Day","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/NDT.S3149","article-title":"Current trends in drug treatment of obsessive-compulsive disorder","volume":"6","author":"Decloedt","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.physbeh.2019.01.013_bb0045","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/npp.2015.292","article-title":"Reductions in cortico-striatal hyperconnectivity accompany successful treatment of obsessive-compulsive disorder with dorsomedial prefrontal rTMS","volume":"41","author":"Dunlop","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.physbeh.2019.01.013_bb0050","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1460-9568.2010.07398.x","article-title":"Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex","volume":"32","author":"Dvorkin","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.physbeh.2019.01.013_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0031-9384(94)00209-N","article-title":"Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole","volume":"57","author":"Einat","year":"1995","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0060","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/jnc.13209","article-title":"Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function","volume":"134","author":"Escobar","year":"2015","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.physbeh.2019.01.013_bb0065","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.biopsych.2010.12.003","article-title":"Dysfunctional reward circuitry in obsessive-compulsive disorder","volume":"69","author":"Figee","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.013_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","article-title":"Randomized, placebo-controlled trial of exposure and ritual prevention, Clomipramine and their combination in the treatment of obsessive-compulsive disorder","volume":"162","author":"Foa","year":"2005","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.physbeh.2019.01.013_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/B:CEMN.0000012717.37839.07","article-title":"Riluzole enhances glutamate uptake in rat astrocyte cultures","volume":"24","author":"Frizzo","year":"2004","journal-title":"Cell. Mol. Neurobiol."},{"issue":"2\u20133","key":"10.1016\/j.physbeh.2019.01.013_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2007.10.023","article-title":"Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1","volume":"578","author":"Fumagalli","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpsychires.2012.09.015","article-title":"Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo controlled study","volume":"47","author":"Ghaleiha","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"26","key":"10.1016\/j.physbeh.2019.01.013_bb0090","doi-asserted-by":"crossref","first-page":"9615","DOI":"10.1523\/JNEUROSCI.0329-15.2015","article-title":"Prefronta and striatal glutamate differently relate to striatal dopamine: potential regulatory mechanisms of striatal presynaptic dopamine function?","volume":"35","author":"Gleich","year":"2015","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.physbeh.2019.01.013_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.psc.2014.06.004","article-title":"Obsessive-compulsive disorder","volume":"37","author":"Goodman","year":"2014","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13063-016-1266-8","article-title":"Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) \u2013 study protocol for a randomized controlled trial","volume":"17","author":"H\u00e4ge","year":"2016","journal-title":"Trials"},{"issue":"11","key":"10.1016\/j.physbeh.2019.01.013_bb0105","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/archgenpsychiatry.2009.152","article-title":"Altered corticostriatal functional connectivity in obsessive-compulsive disorder","volume":"66","author":"Harrison","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"issue":"122","key":"10.1016\/j.physbeh.2019.01.013_bb0110","first-page":"1","article-title":"Spatial reversal learning in chronically sensitized rats and in undrugged sensitized rats with dopamine D2-like receptor agonist quinpirole","volume":"8","author":"Hatalova","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbr.2016.09.042","article-title":"Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder indued by sensitization with d2\/d3 agonist quinpirole","volume":"317","author":"Hatalova","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1056\/NEJMcp031002","article-title":"Obsessive-compulsive disorder","volume":"350","author":"Jenike","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nicl.2013.06.013","article-title":"Abnormal corticostriatal-limbic functional connectivity in obsessive-compulsive disorder during reward processiong and resting-state","volume":"3","author":"Jung","year":"2013","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.physbeh.2019.01.013_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.31887\/DCNS.2010.12.2\/mkellner","article-title":"Drug treatment of obsessive-compulsive disorder","volume":"12","author":"Kellner","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijdevneu.2004.07.009","article-title":"Purinergic modulation of extracellular glutamate levels in the nucleus accumbens in vivo","volume":"22","author":"Kr\u00fcgel","year":"2004","journal-title":"Int. J. Dev. Neurosci."},{"issue":"1","key":"10.1016\/j.physbeh.2019.01.013_bb0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0169-328X(95)00139-J","article-title":"Differentia regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum","volume":"34","author":"Laprade","year":"1995","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0145","first-page":"1","article-title":"Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention","volume":"00","author":"Lieberman","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.physbeh.2019.01.013_bb0150","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1017\/S0954579408000606","article-title":"The neural bases of obsessive\u2013compulsive disorder in children and adults","volume":"20","author":"Maia","year":"2008","journal-title":"Dev. Psychopathol."},{"issue":"3","key":"10.1016\/j.physbeh.2019.01.013_bb0155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","article-title":"Integrating evidence from neuroimaging and neuropsychological studies of obsessive\u2013compulsive disorder: the orbitofronto-striatal model revisited","volume":"32","author":"Menzies","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.physbeh.2019.01.013_bb0160","first-page":"263","article-title":"Memantine augmentation improves symptoms in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a randomized controlled trial","volume":"51","author":"Modarresi","year":"2017","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.physbeh.2019.01.013_bb0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.physbeh.2019.01.013_bb0170","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0175","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.pnpbp.2006.04.013","article-title":"Memantine augmentation for refractory obsessive\u2013compulsive disorder","volume":"30","author":"Pasquini","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.physbeh.2019.01.013_bb0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/JCP.0b013e3181727548","article-title":"Riluzole augmentation in treatment-refractory obsessive\u2013compulsive disorder: a series of 13 cases, with long-term follow-up","volume":"28","author":"Pittenger","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.physbeh.2019.01.013_bb0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40501-015-0051-8","article-title":"Glutamatergic agents for OCD and related disorders","volume":"2","author":"Pittenger","year":"2015","journal-title":"Curr. Treat. Option. Psychiatry"},{"issue":"11","key":"10.1016\/j.physbeh.2019.01.013_bb0190","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1176\/appi.ajp.162.11.2191-a","article-title":"Memantine for treatment-resistant OCD","volume":"162","author":"Poyurovsky","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.physbeh.2019.01.013_bb0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S1461145701002401","article-title":"Brain anatomy and chemistry may predict treatment response in paediatric obsessive-compulsive disorder","volume":"4","author":"Rosenberg","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.physbeh.2019.01.013_bb0200","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuroscience.2009.10.043","article-title":"The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms","volume":"165","author":"Rotge","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2019.01.013_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1300.066","article-title":"Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions","volume":"1003","author":"Seasack","year":"2003","journal-title":"Ann. New York Acad. Sci."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0210","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pnpbp.2017.02.027","article-title":"Preclinical molecular imaging of glutamatergic and dopaminergic neuroreceptor kinetics in obsessive compulsive disorder","volume":"77","author":"Servaes","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.013_bb0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pscychresns.2016.10.003","article-title":"[18F]-FDG PET neuroimaging in rats with quinpirole-induced checking behavior as a model for obsessive compulsive disorder","volume":"257","author":"Servaes","year":"2016","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.physbeh.2019.01.013_bb0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JCP.0b013e3181c856de","article-title":"A single-blinded case\u2013control study of memantine in severe obsessive\u2013compulsive disorder","volume":"30","author":"Stewart","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"209","key":"10.1016\/j.physbeh.2019.01.013_bb0230","first-page":"1","article-title":"Validity of quinpirole sensitization rat model of OCD: linking evidence from animal and clinical studies","volume":"10","author":"Stuchlik","year":"2016","journal-title":"Front. Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.physbeh.2019.01.013_bb0235","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1037\/0735-7044.112.6.1475","article-title":"Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD)","volume":"112","author":"Szechtman","year":"1998","journal-title":"Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.physbeh.2019.01.013_bb0240","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0091-3057(94)90201-1","article-title":"Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole","volume":"48","author":"Szechtman","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.physbeh.2019.01.013_bb0245","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00008877-199308000-00014","article-title":"Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole","volume":"4","author":"Szechtman","year":"1993","journal-title":"Behav. Pharmacol."},{"issue":"22","key":"10.1016\/j.physbeh.2019.01.013_bb0250","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1523\/JNEUROSCI.1021-04.2004","article-title":"Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanism","volume":"24","author":"Tseng","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.013_bb0255","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.neuroimage.2003.05.001","article-title":"Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex","volume":"20","author":"van der Wee","year":"2003","journal-title":"NeuroImage"},{"key":"10.1016\/j.physbeh.2019.01.013_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.g2183","article-title":"Obsessive-compulsive disorder","volume":"348","author":"Veale","year":"2014","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.physbeh.2019.01.013_bb0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0043-118665","article-title":"Role of glutamatergic system in obsessive-compulsive disorder with possible therapeutic implications","volume":"51","author":"Vl\u010dek","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.physbeh.2019.01.013_bb0270","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","article-title":"The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder","volume":"100","author":"Wu","year":"2012","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938418311120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938418311120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T22:33:33Z","timestamp":1606602813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938418311120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":53,"alternative-id":["S0031938418311120"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2019.01.013","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2019.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}